TwitterLinkedin

Contact Us

  • News & Events
    • News
    • Webinars
    • Events
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Working at PharmaLex
    • Your Application Process
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • Our Milestones
    • Corporate Social Responsibility
    • What Our Clients Say About Us
  • Our Services
    • Discovery / Non-clinical

          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Development Strategy and Gap Analysis
            • Integrated Product Development
            • Market Access
            • Non-clinical Development Concept
              and Study Design
            • Scientific Advice
            • Scientific Due Diligence
            • Statistical Services
            • Toxicology Services
    • Clinical Development

          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Clinical Program Development
            • Orphan Drug Designation
            • Pediatric Investigation Plan (PIP)
            • Scientific Advice
            • Statistical Services

          • Regulatory Affairs

            • Clinical Trial Applications
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Regulatory Operations

          • Pharmacovigilance

            • Clinical Trial Safety Support
            • Pharmacovigilance Consulting

          • Quality

            • GxP Services
            • IMP Management
            • Interim / Contract QA
            • Quality Management Systems
            • Tech Transfer / Scale-up
            • Vendor Management and Oversight
    • Authorization / Approval

          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access

          • Regulatory Affairs

            • CMC Services
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Regulatory Operations
            • Scientific, Regulatory and Technical Writing
            • Statistical Services

          • Pharmacovigilance

            • EU QPPV / National QPPV
            • Pharmacovigilance Consulting

          • Quality

            • Commercialization Readiness
            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • PAI Readiness
    • Post-approval / Maintenance

          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Environmental Risk Assessment
            • Market Access

          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Regulatory Operations
            • Toxicology Services

          • Pharmacovigilance

            • Audit and CAPA Management
            • EU QPPV / National QPPV
            • ICSR Management
            • Literature Screening
            • Pharmacovigilance Systems
            • Safety Writing (PSUR, RMP)
            • Signal Management

          • Quality

            • Commissioning, Qualification, and Validation (CQV)
            • Good Distribution Practice (GDP) Compliance
            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
            • Vendor Audit
            • Vendor Management and Oversight

          • Medical Affairs

            • Healthcare Compliance and Medical Approval
            • Medical Information
    • Program Management

          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise

          • Industry Expertise

            • Biopharmaceuticals
            • Consulting
            • Consumer Healthcare
            • Generics
            • Herbal Medicines
            • Medicinal Products
            • MedTech Services
            • Pharmaceutical
            • Veterinary Drugs

          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • Brexit
            • COVID-19 Support
            • Drug Re-purposing / Value-added Medicines
            • GxP Services
            • Market Access
            • Pharmacovigilance Consulting
            • Statistical Services
            • SMARTPHLEX - technology-enabled services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • News
    • Webinars
    • Events
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Working at PharmaLex
    • Your Application Process
    • Career Opportunities
  • Training
Home > News & Events

News & Events

Contamination Control

Contamination Control

8th April 2021

Bayesian Approaches for Incorporating Natural History Data in Studies of Rare and Pediatric Disease

Bayesian Approaches for Incorporating Natural History Data in Studies of Rare and Pediatric Disease

7th April 2021

Rules on Ownership of Medicinal Product stock distributed in Great Britain

Rules on Ownership of Medicinal Product stock distributed in Great Britain

7th April 2021

GET SMART: reliable analytical results & continuous regulatory compliance!

GET SMART: reliable analytical results & continuous regulatory compliance!

30th March 2021

Orphan Drugs for Rare Diseases in Children – Considerations for PIPs and PSPs

Orphan Drugs for Rare Diseases in Children – Considerations for PIPs and PSPs

30th March 2021

PharmaLex expands France BENELUX region

PharmaLex expands France BENELUX region

16th March 2021

Challenges of Advanced Therapy Medicinal Products (ATMPs)

Challenges of Advanced Therapy Medicinal Products (ATMPs)

16th March 2021

PharmaLex broadens biopharma expertise

PharmaLex broadens biopharma expertise

5th March 2021

Supporting M&A in the pharmaceutical / biopharmaceutical industry

Supporting M&A in the pharmaceutical / biopharmaceutical industry

11th February 2021

EU GMP Annex 1

EU GMP Annex 1

25th January 2021

New Partnership Announcement for MEPHARMA and PharmaLex

New Partnership Announcement for MEPHARMA and PharmaLex

21st January 2021

BIO International Convention 2021

BIO International Convention 2021

20th January 2021

DIA RSIDM 2021

DIA RSIDM 2021

20th January 2021

TOPRA Symposium 2021

TOPRA Symposium 2021

19th January 2021

DIA Annual Meeting 2021

DIA Annual Meeting 2021

19th January 2021

BIO Europe Spring 2021

BIO Europe Spring 2021

19th January 2021

DIA Europe 2021

DIA Europe 2021

19th January 2021

SMARTRISK – risk assessment excipient tool

SMARTRISK – risk assessment excipient tool

12th January 2021

Medical Devices in the Digital Health Era

Medical Devices in the Digital Health Era

10th December 2020

Medicinal Cannabis: The Wonder Substance

Medicinal Cannabis: The Wonder Substance

1st December 2020

Regulatory Challenges in the COVID Era

Regulatory Challenges in the COVID Era

1st December 2020

PharmaLex creates specialized biopharma service line

PharmaLex creates specialized biopharma service line

20th October 2020

Hospital Exemption for ATMPs Webinar

Hospital Exemption for ATMPs Webinar

15th October 2020

MEP Eva Maydell opened the seminar: “Innovation in Medicine – ATMPs”

MEP Eva Maydell opened the seminar: “Innovation in Medicine – ATMPs”

14th October 2020

PharmaLex Bulgaria is now an official member of the AmCham

PharmaLex Bulgaria is now an official member of the AmCham

14th October 2020

PharmaLex further strengthens biostatistics services

PharmaLex further strengthens biostatistics services

5th October 2020

Covid19 -Impact on Compliance and Quality Culture

Covid19 -Impact on Compliance and Quality Culture

22nd September 2020

Brexit transition period drawing to a close

Brexit transition period drawing to a close

15th September 2020

Utmost priority – avoiding supply chain disruptions

Utmost priority – avoiding supply chain disruptions

10th September 2020

Taking a pragmatic approach to Brexit

Taking a pragmatic approach to Brexit

9th September 2020
Upcoming Webinars

April 27th, 2021

Orphan Drugs for Rare Diseases in Children – Considerations for PIPs and PSPs

3 PM CET

May 12th, 2021

Bayesian Approaches for Incorporating Natural History Data in Studies of Rare and Pediatric Disease

4 PM CET

Upcoming Events

June 14 - 17th, 2021

BIO International Convention 2021

June 27 - July 1st, 2021

DIA Annual Meeting 2021

September 22 - 24th, 2021

TOPRA Symposium 2021

Recent News
  • Contamination Control
    8th April 2021
  • Rules on Ownership of Medicinal Product stock distributed in Great Britain
    7th April 2021
  • GET SMART: reliable analytical results & continuous regulatory compliance!
    30th March 2021
  • PharmaLex expands France BENELUX region
    16th March 2021
  • Challenges of Advanced Therapy Medicinal Products (ATMPs)
    16th March 2021
  • PharmaLex broadens biopharma expertise
    5th March 2021
Categories
  • All News
  • Webinars
  • Events
Archive
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
Tweets by @PharmaLexGLOBAL
COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY

  • Pharmalex provided the resources we needed to compile Investigational Medicinal Product Dossiers for our biological products. The dossiers were delivered on time with the trusted quality we expected

    Small US Biopharmaceutical Company
    Sr Director Regulatory Affairs CMC
PharmaLex
©2021 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit Logo

#AskTheExpert #TogetherBEYONDCOVID19





    Select your state:

    .
    You can unsubscribe at any time at data.protection@pharmalex.com

    If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

    #TogetherBEYONDCOVID19

    We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for

      Please DO NOT send us event/conference information.
      We will not respond and these will be deleted immediately.





      Select your state:

      .
      You can unsubscribe at any time at       data.protection@pharmalex.com

      Click here to view our Privacy Policy.

      Privacy Policy

      This can be specific information about signing up to the newsletter.

      Pellentesque lobortis, tellus at ultrices ullamcorper, lectus tellus consectetur lectus, id consequat leo quam quis eros. Mauris pellentesque tortor a augue pellentesque ultricies. Phasellus sit amet suscipit orci, vel dapibus ligula. Maecenas at pellentesque lectus, sit amet tristique felis. Integer fringilla risus ac neque mollis, at imperdiet lacus sodales. In vehicula orci sed vulputate interdum. Nunc sagittis non nunc eget sollicitudin.

      Maecenas a mattis erat. Phasellus cursus erat non nisl pulvinar ultricies. Aenean id fringilla libero. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Morbi in ultrices elit. Suspendisse egestas hendrerit est. Integer pellentesque nisl ut justo tempus, nec suscipit dolor luctus. Cras vestibulum elementum tincidunt.

      In compliance with the Spanish Law 15/1999, of Protection of Personal Data and in accordance with regulations approved by the Spanish RD 994/1999 inform you that your data will be part of a file located in Friedrichsdorf (Germany), whose ownership belongs to Pharmalex Spain S.L.U. The purpose of these data is the insertion in a potential job selection process. Inform the user that at any time may exercise their right of access, rectification, and deletion of data through email curriculum@pharmalex.com or to this postal address Pharmalex Spain. Coso 103, 50001 Zaragoza, Spain.